Gutscheinbedingungen

**Gültig bis 14.09.2026 auf Spielzeug, Schreibwaren, Filme, Geschenke & Trends, Musik, tolino eReader & Zubehör, Hörbücher, nicht preisgebundene Bücher und Kalender in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Aufgrund der Buchpreisbindung sind deutschsprachige Bücher und eBooks ausgenommen. Zusätzlich ausgenommen sind Abos & Flatrates, Games, Geschenkkarten/-boxen, Shelfies, Software, Zeitschriften sowie einzelne Artikel von tonies®. Pro Einkauf einmal einlösbar. Nur gültig mit im Onlineshop hinterlegter Bonuscard. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Versandkosten und Services.

Produktbild: Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis
- 11%

Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis

11% sparen

106,99 € UVP 120,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

10.03.2025

Abbildungen

XX, 267 p. 131 illus., 42 illus. in color.

Herausgeber

Pu-Xuan Lu + weitere

Verlag

Springer Singapore

Seitenzahl

267

Maße (L/B/H)

27,9/21/1,5 cm

Gewicht

793 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-981-9983-41-4

Beschreibung

Portrait


Pu-Xuan  Lu
is a Chief Medical Specialist of  Shenzhen Center for Chronic Disease Control,Shenzhen Institute of Pulmonology ; first-level chief physician of The Third People’s Hospital of Shenzhen ; a professor and graduate supervisor of Guangdong Medical University.


His research fields include diagnostic imaging and differential diagnosis of emerging infectious diseases, such as SARS, MERS, AIDS, human infected avian influenza, tuberculosis, hepatitis, and other infectious diseases as well as clinical and basic sciences of emerging infectious diseases.

Professor Lu has edited or co-edited more than 20 academic treatise.
Diagnostic Imaging of Emerging Infectious Diseases
has been published by Springer in November 2015, which obtained national key award for book output in May 2017 by the General Administration of News and Publishing, China.In 2020, he co-edited
Tuberculosis Control in Migrating Population
in Springer, and won the third Springer Nature: China New Development Award in September 2021.
 

Hongzhou Lu
, M.D., Ph.D., the director of Shenzhen Third People's Hospital, a world-renowned scholar of infectious diseases, World’s Top 2% Scientists in 2021 (Stanford University), winner of the Charpak Dubousset Prize of the French National Academy of Medicine, fellow of the American Academy of Microbiology


Prof. Lu has long been dedicated to the basic research and clinical practice of infectious diseases. During the influenza A (H1N1, H7N9) and COVID-19 pandemics, he led the early treatment efforts and pioneered clinical and basic research on related diseases in Shanghai, making essential contributions to the prevention of disease epidemics in China. Professor Lu's work has been supported by the Bill & Melinda Gates Foundation, and the National Institutes of Health. He has published more than 500 research papers in international journals, including
Nature, New England Journal of Medicine, and Cell Research
et al.
 


Yong-xiang Yi
, MD, Vice President of Nanjing Drum Tower Hospital. Distinguish Professor, Ph.D Supervisor of  Nanjing University of Chinese medicine. National Excellent Hospital President. Experts rewarded special government allowances from the State Council. Vice Chairman of Infectious Disease Hospital of China Hospital Association.Vice Chairman of the Liver Disease Committee of the Chinese Association of Research Hospitals and Leader of the Liver Cancer Group. Chairman of infectious disease hospital of Jiangsu Hospital Association.  Chairman of the Infectious Diseases of Jiangsu Association of Traditional Chinese Medicine. 


He has been engaged in general surgery for more than 30 years, and has long been committed to the research of various complicate liver disease, gallbladder and pancreatic tumors, intestinal microbiota. He has conducted multiple national, provincial and municipal scientific research projects, published more than 60 SCI papers, written 7 professional books, and published 2 international patents.


 




Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

10.03.2025

Abbildungen

XX, 267 p. 131 illus., 42 illus. in color.

Herausgeber

Verlag

Springer Singapore

Seitenzahl

267

Maße (L/B/H)

27,9/21/1,5 cm

Gewicht

793 g

Auflage

1. Auflage

Sprache

Englisch

ISBN

978-981-9983-41-4

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Diagnostic Imaging of Drug Resistant Pulmonary Tuberculosis
  • Overview of drug resistant pulmonary tuberculosis.- Occurrence and prevalence of drug resistant pulmonary tuberculosis.- New laboratory tests for drug resistant pulmonary tuberculosis.- Clinical classification, typing, and diagnosis of drug resistant pulmonary tuberculosis.- Imaging diagnosis of single drug resistant pulmonary tuberculosis.- Imaging diagnosis of multidrug resistant pulmonary tuberculosis.- Imaging diagnosis of polydrug resistant pulmonary tuberculosis.- Imaging diagnosis of extensive drug resistant pulmonary tuberculosis.- Imaging diagnosis of Rifampicin resistant pulmonary tuberculosis.- Application of Artificial Intelligence in the diagnosis of drug resistant pulmonary tuberculosis.- Differential imaging diagnosis of drug resistant pulmonary tuberculosis.- Prevention and prognosis of multidrug resistant pulmonary tuberculosis.- Possible treatment of drug-resistant tuberculosis and radiographic response to the treatment.